<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04799340</url>
  </required_header>
  <id_info>
    <org_study_id>R21EY031000</org_study_id>
    <nct_id>NCT04799340</nct_id>
  </id_info>
  <brief_title>Computer-based Training of Face Recollection to Improve Face Recognition in Developmental Prosopagnosia</brief_title>
  <official_title>Characterizing and Remediating Recollection-specific Face Recognition Deficits in Developmental Prosopagnosia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harvard Medical School (HMS and HSDM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Harvard Medical School (HMS and HSDM)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the effectiveness of a cognitive training intervention targeting face&#xD;
      recollection, repetition lag training, at improving face recognition in Developmental&#xD;
      Prosopagnosia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cambridge Face Memory Test</measure>
    <time_frame>15 minutes</time_frame>
    <description>learning and recognizing novel faces</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Face Recollection</measure>
    <time_frame>15 minutes</time_frame>
    <description>old/new face recognition test, extracting familiarity and recollection parameters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Face Perception</measure>
    <time_frame>30 minutes</time_frame>
    <description>composite of face matching tasks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-reported face recognition</measure>
    <time_frame>5 minutes</time_frame>
    <description>questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Face-name learning task</measure>
    <time_frame>15 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Developmental Prosopagnosia</condition>
  <arm_group>
    <arm_group_label>holistic face training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>holistic face training + repetition lag training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>waitlist control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>cognitive training</intervention_name>
    <description>training to improve encoding and recognition of faces</description>
    <arm_group_label>holistic face training</arm_group_label>
    <arm_group_label>holistic face training + repetition lag training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Developmental prosopagnosic participants will be included if they are aged 18-65, have&#xD;
             lifelong histories of face recognition difficulties that impact their everyday life&#xD;
             (i.e., not associated with some event such as a stroke, seizure, etc), and score &gt; 2&#xD;
             standard deviations below the mean on the famous faces test and Cambridge Face Memory&#xD;
             Test. This is in line with our previous studies and others in the literature.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participants will be excluded from the study if they have a developmental social&#xD;
             cognitive disorder such as autism or history of a significant neurological disorder&#xD;
             including hydrocephalus, stroke, moderate to severe traumatic brain injury (TBI),&#xD;
             severe neuromuscular diseases, or severe hypoxia due to cardiac arrest. Patients with&#xD;
             a history of mild TBI or simple concussion will not be excluded as long as it was &gt; 6&#xD;
             months ago and as long as they have not had repeated concussions (&gt;5). Participants&#xD;
             will be excluded if they have impairments that interfere with cognitive performance,&#xD;
             such as uncorrected hearing or vision, lack of English proficiency, musculoskeletal or&#xD;
             other issues. Additionally, participants will be excluded if they have psychiatric&#xD;
             disorders, such as schizophrenia, major depressive disorder, bipolar disorder, chronic&#xD;
             intractable obsessive-compulsive disorder, or agoraphobia. We will include individuals&#xD;
             with a diagnosis of ADHD as long as their medication has been consistent for the past&#xD;
             6 months. We will exclude individuals who are currently dependent on alcohol or other&#xD;
             substances, as this may negatively impact cognitive performance. We will exclude&#xD;
             participants who currently are, or within the last 6 months, participating in a&#xD;
             behavioral or pharmacological intervention.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Joseph M DeGutis, Ph.D.</last_name>
    <phone>510-734-7705</phone>
    <email>degutis@hms.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>VA Boston Healthcare System, 150 S. Huntington Ave.</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph M DeGutis, Ph.D.</last_name>
      <phone>510-734-7705</phone>
      <email>degutis@hms.harvard.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 11, 2021</study_first_submitted>
  <study_first_submitted_qc>March 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2021</study_first_posted>
  <last_update_submitted>March 11, 2021</last_update_submitted>
  <last_update_submitted_qc>March 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harvard Medical School (HMS and HSDM)</investigator_affiliation>
    <investigator_full_name>Joseph DeGutis</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prosopagnosia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

